List of Contents

Transplantation Market Size, Share, and Trends 2024 to 2034

The global transplantation market size was USD 16.36 billion in 2023, estimated at USD 17.73 billion in 2024 and is anticipated to reach around USD 39.19 billion by 2034, expanding at a CAGR of 8% from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 1047
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Transplantation Market, By Product

7.1. Transplantation Market, by Product Type, 2024-2034
7.1.1. Immunosuppressive Drugs
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Tissue Products
7.1.2.1. Market Revenue and Forecast (2021-2034)
7.1.3. Preservation Solution
7.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 8. Global Transplantation Market, By Application

8.1. Transplantation Market, by Application, 2024-2034
8.1.1. Tissue Transplantation
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Organ Transplantation
8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Transplantation Market, By End-use

9.1. Transplantation Market, by End-use, 2024-2034
9.1.1. Transplant Centers
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Transplantation Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2021-2034)
10.1.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.3. Market Revenue and Forecast, by End-use (2021-2034)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.1.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.1.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.1.5.3. Market Revenue and Forecast, by End-use (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2021-2034)
10.2.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.3. Market Revenue and Forecast, by End-use (2021-2034)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.2.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.5.3. Market Revenue and Forecast, by End-use (2021-2034)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
10.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.6.3. Market Revenue and Forecast, by End-use (2021-2034)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
10.2.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.2.7.3. Market Revenue and Forecast, by End-use (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2021-2034)
10.3.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.3. Market Revenue and Forecast, by End-use (2021-2034)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.3.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.5.3. Market Revenue and Forecast, by End-use (2021-2034)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
10.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.6.3. Market Revenue and Forecast, by End-use (2021-2034)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
10.3.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.3.7.3. Market Revenue and Forecast, by End-use (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.4.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.5.3. Market Revenue and Forecast, by End-use (2021-2034)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
10.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.6.3. Market Revenue and Forecast, by End-use (2021-2034)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
10.4.7.2. Market Revenue and Forecast, by Application (2021-2034)
10.4.7.3. Market Revenue and Forecast, by End-use (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.3. Market Revenue and Forecast, by End-use (2021-2034)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
10.5.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.4.3. Market Revenue and Forecast, by End-use (2021-2034)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
10.5.5.2. Market Revenue and Forecast, by Application (2021-2034)
10.5.5.3. Market Revenue and Forecast, by End-use (2021-2034)

Chapter 11. Company Profiles

11.1. Arthrex, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbvie, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Teva Pharmaceuticals
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Medtronic PLC
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Zimmer Biomet
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Strykers
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Novartis AG
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. BiolifeSolutions, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. 21st Century Medicine
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Veloxis Pharmaceutical
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global transplantation market size is expected to reach over USD 39.19 billion by 2034.

Increasing prevalence of chronic disease along with organ failure are the prime factors driving the transplantation market growth.

North America dominated the transplantation market with significant revenue share of nearly 40% in 2019 and analyzed to continue its dominance over the analysis period.

The Asia Pacific encountered the highest CAGR over the forecast period due to increasing investment for medical driven research activities to develop organs and in vitro tissue.

Transplantation is one of the major advancement in the modern day medicine. It is a medical procedure in which missing or damaged organ of one body is replace from the organ of another body.

In 2023, tissue product segment was the highest revenue contributor in the global transplantation market, accounting for a market value share of nearly 59%.

By application, tissue transplantation encountered maximum revenue share of around 60% in the global transplantation market in the year 2023 and expected to grow at the fastest rate over the forecast period.

Hospital segment dominated the global transplantation market with value share of approximately 49.5% in the year 2023 and analyzed to retain its dominance over the forecast period.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us